Alpha-synuclein amyloid accumulation and its interaction with prion protein

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-11-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Staging/typing of Lewy body related alpha-synuclein pathology

  2016cited by this paper
• Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.

  2015influential reference
• α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

  2015influential reference
• Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains

  2015cited by this paper
• Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models*

  2015cited by this paper
• Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review.

  2015influential reference
• Interaction between prion protein and Aβ amyloid fibrils revisited.

  2014cited by this paper
• Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.

  2014cited by this paper
• Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients

  2014cited by this paper
• Conformation Determines the Seeding Potencies of Native and Recombinant Tau Aggregates

  2014cited by this paper
• Pathological alpha-synuclein propagates through neural networks

  2014cited by this paper
• Anti-amyloid Compounds Inhibit α-Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification (PMCA)*

  2014cited by this paper
• Aβ seeds resist inactivation by formaldehyde

  2014cited by this paper
• Noninvasive Bioluminescence Imaging of α-Synuclein Oligomerization in Mouse Brain Using Split Firefly Luciferase Reporters

  2014cited by this paper
• Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system

  2014cited by this paper
• CRISPR-Cas9-Based Knockout of the Prion Protein and Its Effect on the Proteome

  2014influential reference
• Distinct tau prion strains propagate in cells and mice and define different tauopathies.

  2014influential reference
• Distinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice

  2014cited by this paper
• High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.

  2014cited by this paper
• Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

  2014cited by this paper
• Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

  2014cited by this paper
• Peripheral Administration of a Humanized Anti-PrP Antibody Blocks Alzheimer's Disease Aβ Synaptotoxicity

  2014cited by this paper
• Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker

  2014cited by this paper
• Evidence That Bank Vole PrP Is a Universal Acceptor for Prions

  2014cited by this paper
• Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

  2013cited by this paper
• Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue.

  2013cited by this paper
• α-Synuclein Membrane Association Is Regulated by the Rab3a Recycling Machinery and Presynaptic Activity*♦

  2013cited by this paper
• Neurofibrillary tangle‐like tau pathology induced by synthetic tau fibrils in primary neurons over‐expressing mutant tau

  2013cited by this paper
• Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice

  2013cited by this paper
• Brain homogenates from human tauopathies induce tau inclusions in mouse brain

  2013influential reference
• Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy

  2013cited by this paper
• Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds

  2013cited by this paper
• What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?

  2013cited by this paper
• TMARKER: A free software toolkit for histopathological cell counting and staining estimation

  2013cited by this paper
• Prion-like properties of pathological TDP-43 aggregates from diseased brains.

  2013cited by this paper
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseases

  2013cited by this paper
• Convergent replication of mouse synthetic prion strains.

  2013cited by this paper
• Assessing the Subcellular Dynamics of Alpha-synuclein Using Photoactivation Microscopy

  2013cited by this paper
• Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

  2013cited by this paper
• Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization

  2013influential reference
• Transmission of multiple system atrophy prions to transgenic mice

  2013cited by this paper
• Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity

  2013cited by this paper
• Distinct a-Synuclein Strains Differentially Promote Tau Inclusions in Neurons

  2013cited by this paper
• Context dependence of protein misfolding and structural strains in neurodegenerative diseases.

  2013cited by this paper
• “Prion‐Like” Templated Misfolding in Tauopathies

  2013cited by this paper
• An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo*

  2013cited by this paper
• Rabbits are not resistant to prion infection

  2012cited by this paper
• Proteolytic processing of the prion protein in health and disease.

  2012cited by this paper
• Trans-cellular Propagation of Tau Aggregation by Fibrillar Species*

  2012cited by this paper
• Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons

  2012cited by this paper
• Structural Studies of Prion Proteins and Prions

  2012cited by this paper
• Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons*

  2012cited by this paper
• Prion-like acceleration of a synucleinopathy in a transgenic mouse model.

  2012cited by this paper
• α-Synuclein Inhibits Intersynaptic Vesicle Mobility and Maintains Recycling-Pool Homeostasis

  2012cited by this paper
• Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons

  2012cited by this paper
• Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?

  2012cited by this paper
• Protein misfolding cyclic amplification of infectious prions

  2012cited by this paper
• A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice

  2012cited by this paper
• Targeting the cellular prion protein to treat neurodegeneration.

  2012cited by this paper
• Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

  2012influential reference
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cited by this paper
• Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions

  2012cited by this paper
• Gwyddion: an open-source software for SPM data analysis

  2012cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation.

  2011cited by this paper
• Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

  2011cited by this paper
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties.

  2011cited by this paper
• α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

  2011cited by this paper
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia

  2011cited by this paper
• An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity

  2011cited by this paper
• Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles*

  2011cited by this paper
• Tunneling-nanotube development in astrocytes depends on p53 activation

  2011cited by this paper
• Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated α-synuclein.

  2011cited by this paper
• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

  2011influential reference
• Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

  2011cited by this paper
• The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replication

  2011cited by this paper
• Ablation of Cellular Prion Protein Does Not Ameliorate Abnormal Neural Network Activity or Cognitive Dysfunction in the J20 Line of Human Amyloid Precursor Protein Transgenic Mice

  2011cited by this paper
• Neuropathology underlying clinical variability in patients with synucleinopathies

  2011cited by this paper
• A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦

  2011influential reference
• A Naturally Occurring C-terminal Fragment of the Prion Protein (PrP) Delays Disease and Acts as a Dominant-negative Inhibitor of PrPSc Formation*

  2011cited by this paper
• Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays

  2010cited by this paper
• Generating a Prion with Bacterially Expressed Recombinant Prion Protein

  2010cited by this paper
• The genetics of prion diseases

  2010influential reference
• Ribosylation Rapidly Induces α-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products

  2010cited by this paper
• Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy

  2010cited by this paper
• Dopamine quinones interact with alpha-synuclein to form unstructured adducts.

  2010cited by this paper
• Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.

  2010cited by this paper
• Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

  2010cited by this paper
• Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.

  2010influential reference
• Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival

  2010cited by this paper
• Prion Shedding from Olfactory Neurons into Nasal Secretions

  2010cited by this paper
• Protease-Sensitive Synthetic Prions

  2010cited by this paper
• Recombinant prion protein induces a new transmissible prion disease in wild-type animals

  2010cited by this paper
• Superoxide Dismutase 1 and tgSOD1G93A Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Unique Structural Characteristics of the Rabbit Prion Protein*

  2010influential reference
• Anti-PrP monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer’s disease model mouse

  2010cited by this paper

• No citing papers are available for this paper.